封面
市场调查报告书
商品编码
1624439

全球稳定同位素标记化合物市场规模(按类型、最终用途、地区、范围和预测)

Global Stable Isotope Labeled Compounds Market Size By Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15), By End-Use (Research Institutes, Pharmaceutical & Biopharmaceutical), By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

稳定同位素标记化合物的市场规模及预测

稳定同位素标记化合物的市场规模预计在 2021 年价值 2.7823 亿美元,到 2030 年将达到 3.8351 亿美元,2023 年至 2030 年的复合年增长率为 3.64%。该市场的成长主要归功于製药和生物技术领域研究活动的不断增加。此外,癌症发生率的不断上升也刺激了使用稳定同位素标记化合物的研究活动。本研究报告对全球稳定同位素标记化合物市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球稳定同位素标记化合物市场

稳定同位素标记涉及使用非放射性同位素作为示踪剂来模拟各种化学和生化系统。同位素可透过核磁共振(NMR)和质谱(MS)作为化合物的可识别标籤。常用的稳定同位素包括2H、13C和15N。稳定同位素标记化合物引起了从事代谢介导毒性研究的研究人员的极大兴趣。它在大量代谢研究中评估体内代谢的作用变得不容忽视。除了代谢组学研究外,稳定同位素标记化合物越来越多地应用于环境分析、蛋白质组学和医学诊断研究。

稳定同位素标记化合物的全球市场概况

报告的市场展望部分主要涵盖基本市场动态、市场推动因素和课题、市场限制和机会。市场推动因素和阻碍因素是内在因素,市场推动因素和课题是外在因素。

该市场的成长主要受到製药和生物技术领域分析活动增加等因素的推动。此外,癌症发生率的不断上升也刺激了使用稳定同位素标记化合物的分析活动。此外,由于个人化医疗和药品领域的分析活动不断增加,稳定同位素标记化合物市场正在定期增长,预计这将在预测期内促使稳定同位素标记化合物市场健康成长。然而,稳定同位素标记化合物的引入需要较高的资金投入,这是阻碍其成长的最大障碍。

在验证分析中,我们缩小原始资讯的资料利用范围以验证知识,并利用它来汇总全面的分析研究。该报告包含消费者感兴趣的市场部分的定量和定性估计。全球稳定同位素标记化合物市场已细分为多个子市场,可以定期提供有关最新趋势的机密知识。

目录

第 1 章稳定同位素标记化合物全球市场简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章:经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第 4 章 稳定同位素标记化合物的全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析

第5章 全球稳定同位素标记化合物市场(按类型)

  • 概述
  • 碳-13
  • 氮-15
  • 氧-18

第6章 稳定同位素标记化合物的全球市场(依最终用途划分)

  • 概述
  • 研究机构
  • 製药和生物製药
  • 其他

第7章 全球稳定同位素标记化合物市场(按地区)

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第 8 章稳定同位素标记化合物的全球市场:竞争格局
  • 概述
  • 各公司的市场排名
  • 主要发展策略

第9章 公司简介

  • Merck KGaA
  • Cambridge Isotope Laboratories, Inc.
  • PerkinElmer Inc.
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • Taiyo Nippon Sanso Corporation
  • Isosciences
  • Trace Sciences International
  • Alsachim
  • Urenco Stable Isotopes

第 10 章 重大进展

  • 产品发布/开发
  • 合併和收购
  • 业务扩展
  • 伙伴关係和合作关係

第 11 章附录

  • 相关研究
Product Code: 24354

Stable Isotope Labeled Compounds Market Size And Forecast

Stable Isotope Labeled Compounds Market size was valued at USD 278.23 Million in 2021 and is projected to reach USD 383.51 Million by 2030 , growing at a CAGR of 3.64% from 2023 to 2030. The growth of this market is majorly driven by factors such as the increase in research activities in the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled research activities using such stable isotope-labeled compounds. The Global Stable Isotope Labeled Compounds Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Stable Isotope Labeled Compounds Market Definition

Stable isotope labeling includes the use of non-radioactive isotopes which can serve as tracers used to model different chemical and biochemical systems. The isotope can act as an identifiable label on that compound through nuclear magnetic resonance (NMR) and mass spectrometry (MS). The Commonly used stable isotopes include 2H, 13C, and 15N. Stable isotope-labeled compounds have generated considerable interest among researchers engaged in metabolism-mediated toxicity studies. Their role has risen to insignificance in the assessment of in vivo metabolism in a vast range of metabolic research. Apart from metabolomics studies, stable isotope-labeled compounds are being increasingly used in environmental analysis, proteomics, and medical diagnostic research.

Global Stable Isotope Labeled Compounds Market Overview

The report's market outlook section primarily encompasses essential market dynamics, drivers, restraints, opportunities, and challenges the trade faces. Drivers and restraints are intrinsic factors, whereas opportunities and challenges are extrinsic factors of the market.

The growth of this market is majorly driven by factors like the rise in analysis activities within the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled analysis activities using such stable isotope-labeled compounds. Moreover, the increase at intervals in the Stable Isotope Labeled Compounds Market due to the rise in analysis activity, significantly at intervals in the area of customized medicine and medicines, presents a superb chance for the Stable Isotope Labeled Compounds Market to grow healthy over the forecast amount. However, implementing stable isotope-labeled compounds needs high capital investments, which is the most critical barrier to plug growth.

Verified analysis narrows down their data exploitation of primary sources to validate the knowledge and use it in the aggregation of a full-fledged analysis study. The report contains a quantitative and qualitative estimation of market parts that interest the consumer. The "Global Stable Isotope Labeled Compounds Market" is split into sub-segments that can provide classified knowledge regarding the most recent trends at intervals.

Global Stable Isotope Labeled Compounds Market: Segmentation Analysis

The Global Stable Isotope Labeled Compounds Market is Segmented on the basis of Type, End-Use, and Geography.

Stable Isotope Labeled Compounds Market, By Type

  • Deuterium
  • Oxygen-18
  • Carbon-13
  • Nitrogen-15

Based on Type, the market is segmented into Deuterium, Oxygen-18, Carbon-13, and Nitrogen-15. Deuterium accounted for the largest market share in 2019 followed by Oxygen-18. Deuterium-labeled compounds have been utilized efficiently by toxicologists and drug metabolism scientists to gain an understanding of drug disposition and the potential performance of these compounds in the target organ toxicities.

Stable Isotope Labeled Compounds Market, By End-Use

  • Research Institutes
  • Pharmaceutical & Biopharmaceutical
  • Others

Based on End-Use, the market is segmented into Research Institutes, Pharmaceutical & Biopharmaceutical, and Others. Research Institutes accounted for the largest market share in 2019. Government research institutes, medical research institutes, and academic research institutes employ stable isotope-labeled compounds for performing metabolomics and proteomics research studies.

Stable Isotope Labeled Compounds Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Stable Isotope Labeled Compounds Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the major contributor to the Stable Isotope Labeled Compounds Market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the Americas.

Key Players

  • The "Global Stable Isotope Labeled Compounds Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Merck KGaA, Cambridge Isotope Laboratories, Inc., PerkinElmer Inc., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Taiyo Nippon Sanso Corporation, Isosciences, Trace Sciences International, Alsachim, Urenco Stable Isotopes.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with their product benchmark and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In July 2021, Cambridge Isotope Laboratories, Inc. (CIL), part of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled compounds, has launched the first commercially available 12C-enriched methane-grade gas for quantum applications.
  • In July 2021, Bruker has entered into a partnership with Massachusetts-based Cambridge Isotope Laboratories (CIL), formalizing a long-term relationship between the two companies and further extending Bruker's capabilities to deliver end-to-end service solutions to its installed customer base in nuclear magnetic resonance (NMR) spectroscopy under the LabScape(R) brand.
  • In June 2020, Creative Proteomics, the main provider in proteomics and metabolomics services, delivered a few proteomics services to scientists. The assistance ranges incorporate four: iTRAQ naming help, name-free quantitation service, SILAC mass spectrometry service, and TMT proteomics service.
  • In June 2020, Cambridge Isotope Laboratories, (CIL) the largest manufacture and global supplier of stable isotopes and stable isotope-labeled compounds, collaborated with Alsachim to provide antiviral drug standards to researchers and clinicians exclusively in the Americas. These products are available through CIL in convenient packaging sizes and are adept for use as internal standards in therapeutic monitoring and quantitative analysis.
  • In December 2020, Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), recently began a significant capacity optimization of one of the production cascades at the 13C separation facility in Xenia, Ohio. This optimization, which began this past summer and is scheduled for completion in the summer of 2021, will increase the cascade's 13C production by 10%.
  • Merger & Acquisitions
  • In April 2018, TAIYO NIPPON SANSO CORPORATION totally acquired SAIL advances Inc., where it's valuable in assembling and conveying stable isotope-marked amino acids that are material in biotechnology-related businesses and the medication industry.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Carbon-13
  • 5.3 Nitrogen-15
  • 5.4 Deuterium
  • 5.5 Oxygen-18

6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE

  • 6.1 Overview
  • 6.2 Research Institutes
  • 6.3 Pharmaceutical & Biopharmaceutical
  • 6.4 Others

7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Merck KGaA
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Cambridge Isotope Laboratories, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 PerkinElmer Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Medical Isotopes, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Omicron Biochemicals, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Taiyo Nippon Sanso Corporation
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Isosciences
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Trace Sciences International
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Alsachim
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Urenco Stable Isotopes
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research

LIST OF TABLES

  • TABLE 1 PRICING ANALYSIS
  • TABLE 2 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 3 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • TABLE 5 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 6 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 7 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 8 U.S. STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 9 U.S. STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 10 CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 11 CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 12 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 13 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 14 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 15 GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 16 GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 17 ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 18 ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 19 BENELUX STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 20 BENELUX STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 21 UK STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 22 UK STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 23 RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 24 RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 25 SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 26 SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 27 FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 28 FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 29 REST OF EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 30 REST OF EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 31 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 32 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 33 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 34 CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 35 CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 36 JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 37 JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 38 SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 39 SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 40 REST OF ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 41 REST OF ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 45 GCC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 46 GCC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 47 TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 48 TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 49 SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 50 SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 51 NORTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 52 NORTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 53 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 54 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 55 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 56 BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 57 BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 58 MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 59 MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 60 MERCK KGAA: PRODUCT BENCHMARKING
  • TABLE 61 CAMBRIDGE ISOTOPE LABORATORIES, INC.: PRODUCT BENCHMARKING
  • TABLE 62 PERKINELMER INC.: PRODUCT BENCHMARKING
  • TABLE 63 MEDICAL ISOTOPES, INC.: PRODUCT BENCHMARKING
  • TABLE 64 OMICRON BIOCHEMICALS, INC.: PRODUCT BENCHMARKING
  • TABLE 65 TAIYO NIPPON SANSO CORPORATION: PRODUCT BENCHMARKING
  • TABLE 66 ISOSCIENCES: PRODUCT BENCHMARKING
  • TABLE 67 TRACE SCIENCES INTERNATIONAL: PRODUCT BENCHMARKING
  • TABLE 68 ALSACHIM: PRODUCT BENCHMARKING
  • TABLE 69 URENCO STABLE ISOTOPES: PRODUCT BENCHMARKING

LIST OF FIGURES

  • FIGURE 1 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OVERVIEW
  • FIGURE 7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET GEOGRAPHICAL ANALYSIS, 2020- 2027
  • FIGURE 8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY PRODUCT TYPE, (USD MILLION)
  • FIGURE 9 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY APPLICATION (USD MILLION)
  • FIGURE 10 FUTURE MARKET OPPORTUNITIES
  • FIGURE 11 NORTH AMERICA DOMINATED THE MARKET IN 2019
  • FIGURE 12 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK
  • FIGURE 13 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE
  • FIGURE 14 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE
  • FIGURE 15 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • FIGURE 16 NORTH AMERICA MARKET SNAPSHOT
  • FIGURE 17 EUROPE MARKET SNAPSHOT
  • FIGURE 18 ASIA PACIFIC MARKET SNAPSHOT
  • FIGURE 19 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • FIGURE 20 LATIN AMERICA MARKET SNAPSHOT
  • FIGURE 21 MERCK KGAA: COMPANY INSIGHT
  • FIGURE 22 MERCK KGAA: SEGMENT BREAKDOWN
  • FIGURE 23 MERCK KGAA: SWOT ANALYSIS
  • FIGURE 24 CAMBRIDGE ISOTOPE LABORATORIES, INC.: COMPANY INSIGHT
  • FIGURE 25 CAMBRIDGE ISOTOPE LABORATORIES, INC.: SWOT ANALYSIS
  • FIGURE 26 PERKINELMER INC.: COMPANY INSIGHT
  • FIGURE 27 PERKINELMER INC.: SEGMENT BREAKDOWN
  • FIGURE 28 PERKINELMER INC.: SWOT ANALYSIS
  • FIGURE 29 MEDICAL ISOTOPES, INC.: COMPANY INSIGHT
  • FIGURE 30 OMICRON BIOCHEMICALS, INC.: COMPANY INSIGHT
  • FIGURE 31 TAIYO NIPPON SANSO CORPORATION: COMPANY INSIGHT
  • FIGURE 32 TAIYO NIPPON SANSO CORPORATION: SEGMENT BREAKDOWN
  • FIGURE 33 ISOSCIENCES: COMPANY INSIGHT
  • FIGURE 34 TRACE SCIENCES INTERNATIONAL: COMPANY INSIGHT
  • FIGURE 35 ALSACHIM: COMPANY INSIGHT
  • FIGURE 36 URENCO STABLE ISOTOPES: COMPANY INSIGHT